a2z Radiology AI vs Seed Health

Side-by-side comparison of AI visibility scores, market position, and capabilities

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Seed Health

GrowthConsumer Lifestyle & Wellness

Nutritional Supplements

Science-led synbiotic brand; $56M revenue, profitable, top-5 Amazon probiotic ranking, and expanding into AI-driven microbiome research.

About

Seed Health is a Los Angeles-based microbial sciences company founded in 2018 by Ara Katz and Raja Dhir. The company is best known for its DS-01 Daily Synbiotic, a two-in-one probiotic and prebiotic capsule developed in partnership with academic researchers. Seed has raised approximately $44 million in total funding, with a Series A led by The Craftory, and has achieved profitability.\n\nThe company reported approximately $56 million in revenue with 500%+ growth over three years, ranking among Amazon's top-five probiotic supplements and selling in Target stores nationwide. Seed differentiates itself by emphasizing clinical research transparency — each strain is backed by published studies, and the brand has become a go-to reference among health-conscious consumers and clinicians.\n\nBeyond consumer products, Seed operates a scientific research arm called SeedLabs that conducts microbiome research in areas including planetary health and pediatric immunity. In 2024, the company announced an AI-powered initiative to accelerate strain discovery. This dual consumer-science identity gives Seed unusual credibility in a supplement category often criticized for weak evidence.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.